Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis

Immunotherapy and fatigue: what we know and what we don’t know

(2021) Muhammad Azeem Khan et al.   Oncotarget

Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data

(2021) Tigran Makunts et al.   Scientific Reports

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis

(2021) Lorenz H. Lehmann et al.   JAMA Cardiology

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

(2021) John R. Power et al.   CIRCULATION

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

(2021) Bryan J. Schneider et al.   JOURNAL OF CLINICAL ONCOLOGY

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

(2020) Raju K. Vaddepally et al.   Cancers

Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report

(2020) Gabrielle Lie et al.   Translational Lung Cancer Research

Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque

(2020) Zsofia D. Drobni et al.   CIRCULATION

Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases

(2019) Suheil Albert Atallah-Yunes et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cardiac Troponin T and Troponin I in the General Population

(2019) Paul Welsh et al.   CIRCULATION

Myocarditis in the Setting of Cancer Therapeutics

(2019) Marc P. Bonaca et al.   CIRCULATION

Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area

(2018) Hassan Mir et al.   CANADIAN JOURNAL OF CARDIOLOGY

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

(2018) Syed S. Mahmood et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

(2018) Javid J Moslehi et al.   LANCET

Cardiovascular adverse events in immune checkpoint inhibitor clinical trials: A U.S. Food and Drug Administration pooled analysis.

(2018) Laleh Amiri-Kordestani et al.   JOURNAL OF CLINICAL ONCOLOGY

Reporting of immune checkpoint inhibitor-associated myocarditis

(2018) Sadeer G Al-Kindi et al.   LANCET

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

(2018) Daniel Y. Wang et al.   JAMA Oncology

Putting the Immunologic Brakes on Cancer

(2018) Jedd Wolchok   CELL

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

(2018) Joe-Elie Salem et al.   LANCET ONCOLOGY